News

Deal Announcements

FlowCardia Secures $30 Million Series C Funding

Tuesday, September 4, 2007 5:00:00 AM PDT | VentureDeal Staff

SUNNYVALE, CA -- Medical device company FlowCardia, Inc. has received a third round of financing, receiving $30 million from a large syndicate of venture capital firms.

FlowCardia designs and develops technologies to enable the crossing of totally occluded coronary and peripheral arteries. The company's focus is on the treatment of Chronic Total Occlusions.

Investors in the round were lead Glide Healthcare Partners, and included Life Sciences Partners, Pappas Ventures, Frazier Healthcare Ventures, H&Q, New Science Ventures, Rockport Capital Partners, Gold Hill Capital and JPMorgan Partners.

Email Page | Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

About VentureDeal

Founded in 2006, VentureDeal is a database that provides the latest information about venture capital firms, venture-backed technology companies and transactions throughout North America.

Learn More »

Home
Overview
Service Firms
Tech Entrepreneurs
Venture Investors

Services
Subscribe
Use Cases

FAQ
Terms of Use
Privacy Policy
Contact
Login